Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab with Plasma Exchange in Acute TTP
NCT00937131Phase 2Completed
- Sponsor
- University College London
- Start
- Mar 2006
- Primary completion
- Jun 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in thrombotic thrombocytopenic purpura (TTP), sponsored by University College London. Started Mar 2006; status: completed.
02
Drugs
rituximab
03
Conditions
thrombotic thrombocytopenic purpura (TTP)
Beyond the preview
Go deeper on NCT00937131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00937131.